1. Bioavailability of oral trimetrexate in patients with acquired immunodeficiency syndrome;Rogers;Antimicrob. Agents Chemother.,1988
2. Phase I studies with trimetrexate: clinical pharmacology, analytical methodology, and pharmacokinetics;Lin;Cancer Res.,1987
3. Pharmacokinetics of trimetrexate administered by five-day continuous infusion to patients with advanced cancer;Reece;Cancer Res.,1987
4. Trimetrexate: a second generation folate antagonist in clinical trial;Lin;J. Clin. Oncol.,1987
5. Uptake and efficacy of trimetrexate (TMQ, 2,4-diamino-5-methyl-6- ((3,4,5-trimethoxyanilino) methyl)quinazoline), a non-classical antifolate in methotrexate-resistant leukemia cells in vitro;Kamen;Biochem Pharmacol,1984